[Federal Register Volume 83, Number 54 (Tuesday, March 20, 2018)]
[Notices]
[Pages 12194-12195]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-05594]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[60Day-18-18JC; Docket No. CDC-2017-0121]


Proposed Data Collection Submitted for Public Comment and 
Recommendations

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice with comment period.

-----------------------------------------------------------------------

SUMMARY: The Centers for Disease Control and Prevention (CDC), as part 
of its continuing effort to reduce public burden and maximize the 
utility of government information, invites the general public and other 
Federal agencies the opportunity to comment on a proposed and/or 
continuing information collection, as required by the Paperwork 
Reduction Act of 1995. This notice invites comment on a proposed 
information collection project titled Women's Health Needs Study: The 
Health of U.S.-Resident Women from Countries with Prevalent Female 
Genital Mutilation/Cutting (FGM/C).

DATES: CDC must receive written comments on or before May 21, 2018.

ADDRESSES: You may submit comments, identified by Docket No. CDC-2017-
0121 by any of the following methods:
     Federal eRulemaking Portal: Regulations.gov. Follow the 
instructions for submitting comments.
     Mail: Leroy A. Richardson, Information Collection Review 
Office, Centers for Disease Control and Prevention, 1600 Clifton Road 
NE, MS-D74, Atlanta, Georgia 30329.
    Instructions: All submissions received must include the agency name 
and Docket Number. CDC will post, without change, all relevant comments 
to Regulations.gov.
    Please note: Submit all comments through the Federal eRulemaking 
portal (regulations.gov) or by U.S. mail to the address listed above.

FOR FURTHER INFORMATION CONTACT: To request more information on the 
proposed project or to obtain a copy of the information collection plan 
and instruments, contact Leroy A. Richardson, Information Collection 
Review Office, Centers for Disease Control and Prevention, 1600 Clifton 
Road NE, MS-D74, Atlanta, Georgia 30329; phone: 404-639-7570; Email: 
[email protected].

SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995 
(PRA) (44 U.S.C. 3501-3520), Federal agencies must obtain approval from 
the Office of Management and Budget (OMB) for each collection of 
information they conduct or sponsor. In addition, the PRA also requires 
Federal agencies to provide a 60-day notice in the Federal Register 
concerning each proposed collection of information, including each new 
proposed collection, each proposed extension of existing collection of 
information, and each reinstatement of previously approved information 
collection before submitting the collection to the OMB for approval. To 
comply with this requirement, we are publishing this notice of a 
proposed data collection as described below.
    The OMB is particularly interested in comments that will help:
    1. Evaluate whether the proposed collection of information is 
necessary for the proper performance of the functions of the agency, 
including whether the information will have practical utility;
    2. Evaluate the accuracy of the agency's estimate of the burden of 
the proposed collection of information, including the validity of the 
methodology and assumptions used;
    3. Enhance the quality, utility, and clarity of the information to 
be collected; and
    4. Minimize the burden of the collection of information on those 
who are to respond, including through the use of appropriate automated, 
electronic, mechanical, or other technological collection techniques or 
other forms of information technology, e.g., permitting electronic 
submissions of responses.
    5. Assess information collection costs.

Proposed Project

    Women's Health Needs Study: The Health of U.S.-Resident Women from 
Countries with Prevalent Female Genital Mutilation/Cutting (FGM/C)--
New--National Center for Chronic Disease Prevention and Health 
Promotion (NCCDPHP), Centers for Disease Control and Prevention (CDC).

[[Page 12195]]

Background and Brief Description

    Female Genital Mutilation/Cutting (FGM/C) is a practice common in 
many countries in parts of Asia, Africa and the Middle East that can 
have severe, deleterious health consequences for women and girls. 
Recent studies suggest that more than 500,000 women and girls in the 
United States may have been cut or be at risk for FGM/C based on 
whether women or their mothers are from countries with high prevalence 
of FGM/C. However, this estimate was derived using indirect techniques 
that do not account for the differing characteristics of women in the 
country of origin versus those who have migrated to the United States, 
or any other factors that are likely to affect the prevalence of FGM/C. 
Additional major knowledge gaps regarding FGM/C in the United States 
include: The prevalence of FGM/C in selected communities in the United 
States with high concentrations of residents from countries where FGM/C 
is prevalent; women's attitudes about continuance of the practice; and 
the health characteristics and needs of women living in the United 
States who have experienced FGM/C or are at risk for FGM/C.
    This study aims to capture information on women's history of FGM/C, 
their experiences with health care services, and their attitudes about 
continuation of the FGM/C practice. Findings from this study will be 
used to identify public health needs of women and communities in the 
United States that are affected by FGM/C, to formulate public health 
strategies to meet identified needs, and to inform prevention efforts.
    The proposed information collection will include piloting and 
conducting a full-scale survey of the health experiences and needs of 
women who live in selected communities in the United States with high 
concentrations of residents from countries where FGM/C is widely 
practiced. The pilot study will be conducted during the first year of 
this project and will be used to assess the feasibility of sampling and 
recruiting methods for a hard-to-reach population on a sensitive topic. 
Based on findings from the pilot, a change request, including necessary 
translations, will be submitted to conduct the full study during the 
second and third year of this project. The full study is planned to be 
implemented in up to five community sites in the United States. The 
estimated annualized burden over the three years of this project is 311 
hours.
    There are no costs to respondents other than their time to 
participate.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                     Number of    Average burden
      Type of respondents           Form name        Number of     responses per   per response    Total burden
                                                    respondents     respondent      (in hours)      (in hours)
----------------------------------------------------------------------------------------------------------------
Women age 18 to 49 who were     WHNS Eligibility             667               1            1/60              11
 born in, or whose mother was    Screener.
 born in, an FGM/C practicing
 country.
Women age 18-49 who were born   WHNS                         400               1           45/60             300
 in, or whose mother was born    Questionnaire.
 in, an FGM/C practicing
 country.
                                                 ---------------------------------------------------------------
    Total.....................  ................  ..............  ..............  ..............             311
----------------------------------------------------------------------------------------------------------------


Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific 
Integrity, Office of the Associate Director for Science, Office of the 
Director, Centers for Disease Control and Prevention.
[FR Doc. 2018-05594 Filed 3-19-18; 8:45 am]
BILLING CODE 4163-18-P